Northwest Bancshares’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $715K | Hold |
25,446
| – | – | 0.14% | 98 |
|
|
2025
Q4 | $634K | Sell |
25,446
-3,189
| -11% | -$80.4K | 0.12% | 99 |
|
|
2025
Q3 | $730K | Buy |
28,635
+710
| +3% | +$17.5K | 0.12% | 97 |
|
|
2025
Q2 | $677K | Buy |
27,925
+1,282
| +5% | +$29.9K | 0.12% | 104 |
|
|
2025
Q1 | $675K | Sell |
26,643
-111
| -0.4% | -$2.9K | 0.12% | 100 |
|
|
2024
Q4 | $710K | Sell |
26,754
-5,808
| -18% | -$158K | 0.13% | 97 |
|
|
2024
Q3 | $942K | Sell |
32,562
-2,903
| -8% | -$84.7K | 0.16% | 92 |
|
|
2024
Q2 | $992K | Sell |
35,465
-2,590
| -7% | -$71.3K | 0.17% | 80 |
|
|
2024
Q1 | $1.06M | Sell |
38,055
-5,227
| -12% | -$145K | 0.17% | 83 |
|
|
2023
Q4 | $1.25M | Sell |
43,282
-5,769
| -12% | -$174K | 0.23% | 68 |
|
|
2023
Q3 | $1.63M | Buy |
49,051
+893
| +2% | +$31.6K | 0.31% | 64 |
|
|
2023
Q2 | $1.77M | Sell |
48,158
-95
| -0.2% | -$3.7K | 0.32% | 65 |
|
|
2023
Q1 | $1.97M | Sell |
48,253
-2,014
| -4% | -$87K | 0.38% | 61 |
|
|
2022
Q4 | $2.58M | Sell |
50,267
-1,930
| -4% | -$92.5K | 0.52% | 52 |
|
|
2022
Q3 | $2.29M | Sell |
52,197
-918
| -2% | -$44.6K | 0.53% | 52 |
|
|
2022
Q2 | $2.79M | Sell |
53,115
-1,027
| -2% | -$52.3K | 0.63% | 50 |
|
|
2022
Q1 | $2.8M | Sell |
54,142
-510
| -0.9% | -$26.5K | 0.54% | 53 |
|
|
2021
Q4 | $3.23M | Sell |
54,652
-16
| -0% | -$793 | 0.63% | 51 |
|
|
2021
Q3 | $2.35M | Sell |
54,668
-428
| -0.8% | -$19K | 0.54% | 56 |
|
|
2021
Q2 | $2.16M | Buy |
55,096
+686
| +1% | +$26.7K | 0.49% | 57 |
|
|
2021
Q1 | $1.97M | Buy |
54,410
+4,015
| +8% | +$143K | 0.47% | 64 |
|
|
2020
Q4 | $1.85M | Sell |
50,395
-11,970
| -19% | -$439K | 0.48% | 64 |
|
|
2020
Q3 | $2.17M | Buy |
62,365
+846
| +1% | +$29.7K | 0.56% | 62 |
|
|
2020
Q2 | $1.91M | Buy |
61,519
+18,142
| +42% | +$616K | 0.52% | 65 |
|
|
2020
Q1 | $1.34M | Sell |
43,377
-2,161
| -5% | -$73.6K | 0.67% | 51 |
|
|
2019
Q4 | $1.69M | Sell |
45,538
-847
| -2% | -$30.2K | 0.65% | 52 |
|
|
2019
Q3 | $1.58M | Sell |
46,385
-622
| -1% | -$22.6K | 0.65% | 54 |
|
|
2019
Q2 | $1.93M | Buy |
47,007
+391
| +0.8% | +$15.5K | 0.81% | 49 |
|
|
2019
Q1 | $1.88M | Sell |
46,616
-528
| -1% | -$21.1K | 0.81% | 49 |
|
|
2018
Q4 | $1.95M | Sell |
47,144
-2,270
| -5% | -$94.2K | 0.94% | 46 |
|
|
2018
Q3 | $2.07M | Buy |
49,414
+107
| +0.2% | +$4.12K | 0.91% | 29 |
|
|
2018
Q2 | $1.7M | Sell |
49,307
-712
| -1% | -$24.3K | 0.72% | 33 |
|
|
2018
Q1 | $1.68M | Sell |
50,019
-105
| -0.2% | -$3.61K | 0.69% | 33 |
|
|
2017
Q4 | $1.72M | Buy |
+50,124
| New | +$1.71M | 0.7% | 32 |
|
Other funds holding PFE
VCM
VPM
Northwest Bancshares's PFE Position: Q1 2026 in Review
Northwest Bancshares held its Pfizer (PFE) position steady in Q1 2026 at 25,446 shares worth $715K. The position accounts for 0.14% of the portfolio, ranked #98.
Northwest Bancshares first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.23M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Northwest Bancshares held 25,446 shares of Pfizer worth $715K as of Q1 2026.
- Northwest Bancshares left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.14% of Northwest Bancshares's portfolio in Q1 2026, its #98 holding.
- Northwest Bancshares first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
- Northwest Bancshares's Pfizer position peaked at $3.23M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Northwest Bancshares's 13F filing for Q1 2026, filed 12 May 2026.